| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.097 | 0.1 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |